Vulnerability · CVE-2026-22183
wpDiscuz before 7.6.47 contains a stored cross-site scripting vulnerability in the inline comment preview functionality that allows authenticated users to inject malic…
Published Mar 13, 2026 · catalog updated Jun 17, 2026 · the affected product
Check if you run it
No confirmed exploitation is on record for CVE-2026-22183. EPSS is 0.18%. Act only if a listed version of the affected product is installed.
Gaps on this record
- No plain product name is stored. The page cannot tell you which product to check.
- No version range is stored. A customer cannot check an installed version against this record.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Medium5.3
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.18%
- Remediation
- Advisory link
- Affected products
- cpe gvectors/wpdiscuz
wpDiscuz before 7.6.47 contains a stored cross-site scripting vulnerability in the inline comment preview functionality that allows authenticated users to inject malicious scripts by submitting comments with unescaped content. Attackers with unfiltered_html capabilities can inject JavaScript directly through comment content rendered in the AJAX response from the getLastInlineComments() function in class.WpdiscuzHelperAjax.php without proper HTML escaping.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- cpe gvectors/wpdiscuzversion unspecified
How to fix CVE-2026-22183
Recommended remediation
A patch or advisory reference is linked. Open the original publisher for availability by product version.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2026-22183. EPSS is 0.18%. Act only if a listed version of the affected product is installed.
Which versions are affected?
Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-79: Cross-site Scripting (XSS). EPSS 0.18%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Mar 13, 2026 · NIST NVD
Detected
wpDiscuz before 7.6.47 contains a stored cross-site scripting vulnerability in the inline comment preview functionality that allows authenticated users to inject malicious scripts by submitting comments with unescaped content. Attackers with unfiltered_html capabilities can inject JavaScript directly through comment content rendered in the AJAX response from the getLastInlineComments() function in
Jun 17, 2026 · NIST NVD
Updated
wpDiscuz before 7.6.47 contains a stored cross-site scripting vulnerability in the inline comment preview functionality that allows authenticated users to inject malicious scripts by submitting comments with unescaped content. Attackers with unfiltered_html capabilities can inject JavaScript directly through comment content rendered in the AJAX response from the getLastInlineComments() function in
Sources
- CVE.orgVulnerability recordCVE-2026-22183
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2026-22183
30-day exploitation probability 0.2%
first.org - NIST NVDVulnerability recordCVE-2026-22183
wpDiscuz before 7.6.47 contains a stored cross-site scripting vulnerability in the inline comment preview functionality that allows authenticated users to inject malicious scripts by submitting comments with unescaped content. Attackers with unfiltered_html capabilities can injec
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.